ABT-072

Abbott Presents Positive Results From Phase 2 "Pilot" Study Of An Interferon-Free Combination Regimen For The Treatment Of Hepatitis C
Pharmaceutical Online
Sat, 04/21/12 - 01:03 pm
Abbott Laboratories
ABT-072
ABT-450
hepatitis C
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Abbott Hepatitis C Therapy Works After Other Drugs Fail
Bloomberg
Wed, 04/4/12 - 11:15 am
Abbott Laboratories
hepatitis C
ABT-450
ABT-072
Pharmasset Falls on Rival Abbott Hepatitis C Therapy Results
Reuters
Sat, 10/22/11 - 12:20 pm
Pharmasset
Abbott Laboratories
hepatitis C
ABT-450
protease inhibitors
ABT-333
ABT-072